Nifty
:
24273.80
Sensex
:
80334.81
-140.60 (-0.58%)
-411.97 (-0.51%)
Nifty
Sensex
:
:
24273.80
80334.81
-140.60 (-0.58%)
-411.97 (-0.51%)

Kilitch Drugs (India) Ltd.

Pharmaceuticals & Drugs

Rating :
N/A

BSE: 524500 | NSE: KILITCH

NSE BSE
319.30
06-Feb-2025
  • Open
  • High
  • Low
  • Previous Close
  •  322.00
  •  338.00
  •  315.30
  •  318.30
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  4544
  •  14.78
  •  431.00
  •  299.95

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 580.81
  • 29.77
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 606.95
  • N/A
  • 2.98

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 69.23%
  • 1.72%
  • 25.57%
  • FII
  • DII
  • Others
  • 0%
  • 0.00%
  • 3.48%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 23.29
  • 23.69
  • 10.56

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • 77.16
  • 18.23

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • 77.04
  • 25.68

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 40.12
  • 39.11
  • 33.22

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 1.96
  • 2.19
  • 2.54

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 13.10
  • 24.50
  • 18.61

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Dec 24
Dec 23
Var%
Sep 24
Sep 23
Var%
Jun 24
Jun 23
Var%
Mar 24
Mar 23
Var%
Net Sales
56.17
31.79
76.69%
47.48
41.20
15.24%
33.45
36.56
-8.51%
44.82
45.48
-1.45%
Expenses
47.43
29.51
60.73%
41.38
32.58
27.01%
31.79
30.38
4.64%
37.74
39.26
-3.87%
EBITDA
8.73
2.28
282.89%
6.09
8.62
-29.35%
1.66
6.18
-73.14%
7.08
6.21
14.01%
EBIDTM
15.55%
7.17%
12.83%
20.92%
4.96%
16.91%
15.79%
13.66%
Other Income
1.73
2.96
-41.55%
5.16
0.49
953.06%
2.57
0.56
358.93%
0.47
1.02
-53.92%
Interest
1.40
1.60
-12.50%
0.31
1.51
-79.47%
1.73
1.50
15.33%
1.32
1.21
9.09%
Depreciation
0.81
0.82
-1.22%
0.61
0.82
-25.61%
0.85
0.79
7.59%
0.93
0.91
2.20%
PBT
8.25
2.82
192.55%
10.35
6.78
52.65%
1.65
4.45
-62.92%
5.30
5.11
3.72%
Tax
2.64
1.08
144.44%
1.73
1.69
2.37%
1.54
1.39
10.79%
1.62
2.21
-26.70%
PAT
5.61
1.74
222.41%
8.61
5.09
69.16%
0.11
3.06
-96.41%
3.68
2.90
26.90%
PATM
9.99%
5.48%
18.14%
12.36%
0.33%
8.37%
8.22%
6.38%
EPS
3.71
1.81
104.97%
5.36
2.95
81.69%
0.83
2.15
-61.40%
2.23
2.29
-2.62%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Net Sales
181.92
154.37
139.60
114.23
68.52
53.32
82.49
51.01
28.65
20.99
19.03
Net Sales Growth
17.35%
10.58%
22.21%
66.71%
28.51%
-35.36%
61.71%
78.05%
36.49%
10.30%
 
Cost Of Goods Sold
100.65
78.96
74.76
65.43
37.31
29.09
48.17
26.00
11.25
8.73
7.02
Gross Profit
81.27
75.41
64.84
48.80
31.22
24.23
34.32
25.01
17.39
12.25
12.01
GP Margin
44.68%
48.85%
46.45%
42.72%
45.56%
45.44%
41.61%
49.03%
60.70%
58.36%
63.11%
Total Expenditure
158.34
130.11
121.87
103.73
63.21
53.33
76.47
45.71
29.20
25.29
20.79
Power & Fuel Cost
-
2.43
2.15
2.25
1.63
1.68
1.48
1.15
1.10
0.97
0.82
% Of Sales
-
1.57%
1.54%
1.97%
2.38%
3.15%
1.79%
2.25%
3.84%
4.62%
4.31%
Employee Cost
-
10.01
11.73
6.18
5.24
5.69
5.28
4.30
3.38
3.47
3.13
% Of Sales
-
6.48%
8.40%
5.41%
7.65%
10.67%
6.40%
8.43%
11.80%
16.53%
16.45%
Manufacturing Exp.
-
4.76
5.37
7.76
3.65
3.55
2.88
2.18
2.73
2.68
1.66
% Of Sales
-
3.08%
3.85%
6.79%
5.33%
6.66%
3.49%
4.27%
9.53%
12.77%
8.72%
General & Admin Exp.
-
22.04
8.73
6.46
5.71
6.32
4.78
3.27
2.80
2.71
2.52
% Of Sales
-
14.28%
6.25%
5.66%
8.33%
11.85%
5.79%
6.41%
9.77%
12.91%
13.24%
Selling & Distn. Exp.
-
6.20
14.81
11.42
7.22
6.20
8.64
5.22
4.71
3.46
2.00
% Of Sales
-
4.02%
10.61%
10.00%
10.54%
11.63%
10.47%
10.23%
16.44%
16.48%
10.51%
Miscellaneous Exp.
-
5.70
4.32
4.22
2.44
0.80
5.24
3.59
3.21
3.27
2.00
% Of Sales
-
3.69%
3.09%
3.69%
3.56%
1.50%
6.35%
7.04%
11.20%
15.58%
19.13%
EBITDA
23.56
24.26
17.73
10.50
5.31
-0.01
6.02
5.30
-0.55
-4.30
-1.76
EBITDA Margin
12.95%
15.72%
12.70%
9.19%
7.75%
-0.02%
7.30%
10.39%
-1.92%
-20.49%
-9.25%
Other Income
9.93
4.48
2.92
2.91
2.67
4.55
5.26
3.27
1.14
2.78
2.72
Interest
4.76
6.04
5.08
1.33
0.88
0.94
0.65
0.42
0.16
0.06
0.05
Depreciation
3.20
3.35
3.55
2.47
1.99
2.00
2.05
2.04
9.76
10.05
1.85
PBT
25.55
19.35
12.01
9.61
5.12
1.61
8.59
6.11
-9.32
-11.63
-0.95
Tax
7.53
5.78
3.73
3.40
1.35
0.77
4.76
0.96
-0.43
-0.44
-0.66
Tax Rate
29.47%
29.87%
31.06%
35.38%
26.37%
47.83%
55.41%
15.71%
4.61%
3.78%
69.47%
PAT
18.01
14.61
10.45
7.36
3.67
0.84
3.83
5.15
-8.89
-11.19
-0.29
PAT before Minority Interest
19.51
13.58
8.28
6.21
3.77
0.84
3.83
5.15
-8.89
-11.19
-0.29
Minority Interest
1.50
1.03
2.17
1.15
-0.10
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
9.90%
9.46%
7.49%
6.44%
5.36%
1.58%
4.64%
10.10%
-31.03%
-53.31%
-1.52%
PAT Growth
40.81%
39.81%
41.98%
100.54%
336.90%
-78.07%
-25.63%
-
-
-
 
EPS
11.19
9.07
6.49
4.57
2.28
0.52
2.38
3.20
-5.52
-6.95
-0.18

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Shareholder's Funds
176.29
151.60
139.09
127.13
118.25
121.06
112.03
101.20
108.69
119.88
Share Capital
16.08
15.58
15.58
15.49
15.43
15.36
13.73
13.23
13.23
13.23
Total Reserves
159.85
130.66
120.65
111.28
101.63
104.58
94.56
86.59
94.08
105.27
Non-Current Liabilities
-2.39
-1.91
-1.24
-0.90
-0.58
-0.62
-1.55
-2.47
-0.95
-0.51
Secured Loans
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
0.17
0.07
0.28
0.38
0.39
0.41
0.00
0.00
0.00
0.00
Current Liabilities
64.22
68.87
69.28
73.32
21.97
20.09
14.92
11.69
7.99
6.85
Trade Payables
25.59
40.87
42.87
53.65
7.10
4.35
7.72
5.68
3.69
2.39
Other Current Liabilities
0.28
0.25
0.57
1.41
1.22
3.89
3.50
3.22
3.35
3.92
Short Term Borrowings
31.65
22.19
20.43
14.80
12.61
9.45
0.92
0.69
0.19
0.00
Short Term Provisions
6.70
5.56
5.41
3.45
1.04
2.40
2.78
2.11
0.77
0.55
Total Liabilities
237.50
217.54
208.34
201.90
141.86
142.63
126.13
110.42
115.73
126.22
Net Block
61.98
64.22
64.54
29.96
31.53
32.13
32.96
33.31
42.41
9.38
Gross Block
112.39
111.28
108.05
71.01
70.59
69.19
67.97
66.28
65.62
22.55
Accumulated Depreciation
50.41
47.06
43.51
41.05
39.06
37.06
35.01
32.97
23.21
13.16
Non Current Assets
91.51
91.14
94.23
121.53
86.08
77.75
63.14
61.85
68.43
79.48
Capital Work in Progress
5.96
3.62
3.16
65.48
29.60
20.25
3.18
0.66
0.00
0.00
Non Current Investment
22.83
22.66
23.93
23.88
24.05
25.02
26.00
27.01
25.82
47.16
Long Term Loans & Adv.
0.72
0.62
0.46
0.44
0.36
0.34
0.22
0.08
0.20
22.94
Other Non Current Assets
0.01
0.02
2.14
1.76
0.54
0.00
0.79
0.79
0.00
0.00
Current Assets
145.99
126.40
114.10
80.36
55.79
64.88
62.98
48.57
47.27
46.72
Current Investments
49.43
39.20
47.23
36.40
27.81
28.42
30.29
26.02
23.12
24.67
Inventories
3.99
2.04
5.00
3.59
5.56
4.72
2.80
2.60
2.62
2.38
Sundry Debtors
63.22
54.29
41.41
22.92
15.86
19.44
20.69
14.61
16.37
12.62
Cash & Bank
19.64
19.98
10.06
12.50
2.80
7.94
4.77
2.29
2.75
4.98
Other Current Assets
9.71
0.54
0.36
0.05
3.77
4.37
4.43
3.05
2.41
2.07
Short Term Loans & Adv.
8.00
10.35
10.04
4.91
3.73
4.21
4.07
2.98
2.38
2.00
Net Current Assets
81.78
57.53
44.83
7.05
33.81
44.78
48.07
36.87
39.28
39.87
Total Assets
237.50
217.54
208.33
201.89
141.87
142.63
126.12
110.42
115.73
126.23

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Cash From Operating Activity
-0.15
2.59
5.78
45.66
4.46
0.29
1.42
1.12
17.23
-7.62
PBT
19.35
12.01
9.61
5.12
1.61
8.59
6.11
-9.32
-11.63
-0.95
Adjustment
11.85
9.79
3.89
2.80
-1.23
1.87
2.03
11.49
9.17
2.08
Changes in Working Capital
-24.31
-14.88
-5.19
38.75
6.33
-5.99
-6.70
-1.08
19.71
-8.70
Cash after chg. in Working capital
6.89
6.92
8.32
46.67
6.71
4.47
1.44
1.09
17.25
-7.56
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-7.04
-4.33
-2.54
-1.01
-2.25
-4.18
-0.02
0.03
-0.02
-0.06
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-9.54
7.92
-15.25
-37.57
-10.45
-13.98
-4.45
-1.53
-19.57
-31.20
Net Fixed Assets
-6.52
-3.54
-8.20
-0.42
-1.00
-1.67
-0.87
-0.66
-0.56
-2.00
Net Investments
-10.40
7.08
-10.88
-8.42
1.58
0.88
-4.21
-4.10
-20.40
68.35
Others
7.38
4.38
3.83
-28.73
-11.03
-13.19
0.63
3.23
1.39
-97.55
Cash from Financing Activity
8.81
-0.72
7.03
1.61
0.85
16.86
5.51
-0.04
0.11
-0.06
Net Cash Inflow / Outflow
-0.88
9.78
-2.44
9.70
-5.14
3.17
2.48
-0.45
-2.23
-38.87
Opening Cash & Equivalents
19.85
10.06
12.50
2.80
7.94
4.77
2.29
2.75
4.98
43.85
Closing Cash & Equivalent
18.96
19.85
10.06
12.50
2.80
7.94
4.77
2.29
2.75
4.98

Financial Ratios

Consolidated /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Book Value (Rs.)
109.40
93.85
87.43
81.82
75.85
78.11
78.86
75.44
81.07
89.54
ROA
5.97%
3.89%
3.03%
2.19%
0.59%
2.85%
4.36%
-7.86%
-9.25%
-0.19%
ROE
8.43%
5.86%
4.73%
3.09%
0.71%
3.36%
4.95%
-8.59%
-9.91%
-0.25%
ROCE
13.30%
10.26%
7.26%
4.40%
1.95%
7.59%
6.08%
-8.69%
-10.11%
-0.74%
Fixed Asset Turnover
1.38
1.27
1.28
0.97
0.76
1.20
0.76
0.44
0.48
0.88
Receivable days
138.92
125.11
102.77
103.03
120.72
88.79
125.86
197.00
252.10
265.25
Inventory Days
7.13
9.21
13.72
24.29
35.14
16.62
19.22
33.17
43.50
44.88
Payable days
153.61
204.43
269.21
297.22
42.27
32.14
59.43
52.58
37.09
69.84
Cash Conversion Cycle
-7.56
-70.11
-152.72
-169.89
113.59
73.27
85.65
177.59
258.51
240.30
Total Debt/Equity
0.18
0.15
0.15
0.12
0.11
0.08
0.01
0.01
0.00
0.00
Interest Cover
4.21
3.36
8.22
6.84
2.71
14.25
15.68
-58.98
-183.29
-17.71

Annual Reports:

FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
FY 2019
FY 2018
FY 2017
FY 2016
FY 2015
FY 2014
FY 2013

News Update:


  • Kilitch Drugs(India) - Quarterly Results
    11th Feb 2025, 18:23 PM

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.